In vivo imaging of abdominal aortic aneurysms: Increased FDG uptake suggests inflammation in the aneurysm wall

Journal of Endovascular Therapy

Volumn 15, Issue 4, 2008, Pages 462-467

  Truijers, Maarten ^a   Kurvers, Harrie A J M ^a   Bredie, Sebastian J H ^a   Oyen, Wim J G ^a   Blankensteijn, Jan D ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Abdominal aortic aneurysm; Computed tomography; Positron emission tomography; Vascular inflammation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL AORTA ANEURYSM; AGED; AORTA; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG UPTAKE; HUMAN; INFLAMMATION; LUNG CANCER; MALE; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE;

AGED; AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MALE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 49449114513     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/08-2447.1     Document Type: Article

References (26)

1. Crane C. Arteriosclerotic aneurysm of the abdominal aorta; some pathological and clinical correlations. N Engl J Med. 1955;253:954-958.
2. Fillinger M. Who should we operate on and how do we decide: predicting rupture and survival in patients with aortic aneurysm. Semin Vasc Surg. 2007;20:121-127.
3. Darling RC, Messina CR, Brewster DC, et al. Autopsy study of unoperated abdominal aortic aneurysms. The case for early resection. Circulation. 1977;56:11161-11164.
4. Nicholls SC, Gardner JB, Meissner MH, et al. Rupture in small abdominal aortic aneurysms. J Vasc Surg. 1998;28:884-888.
5. Choke E, Cockerill G, Wilson WR, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227-244.
6. Yamamoto K, Ikeda U, Shimada K. Role of mechanical stress in monocytes/macrophages: implications for atherosclerosis. Curr Vasc Pharmacol. 2003;1:315-319.
7. Sho E, Sho M, Hoshina K, et al. Hemodynamic forces regulate mural macrophage infiltration in experimental aortic aneurysms. Exp Mol Pathol. 2004;76:108-116.
8. Yang JH, Sakamoto H, Xu EC, et al. Biomechanical regulation of human monocyte/macrophage molecular function. Am J Pathol. 2000;156:1797-1804.
9. Ailawadi G, Eliason JL, Upchurch GR. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg. 2003;38:584-588.
10. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29-37.
11. Vos FJ, Bleeker-Rovers CP, Corstens FH, et al. FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging. 2006;50:121-130.
12. Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg. 2004;17:144-153.
13. Defawe OD, Hustinx R, Defraigne JO, et al. Distribution of F-18 fluorodeoxyglucose 〈F-18 FDG〉 in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med. 2005;30:340-341.
14. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
15. Davies JR, Rudd JH, Fryer TD, et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36:2642-2647.
16. Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-896.
17. Tatsumi M, Cohade C, Nakamoto Y, et al. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-837.
18. Wu YW, Kao HL, Chen MF, et al. Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med. 2007;48:227-233.
19. Sakalihasan N, Van DH, Gomez P, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2002;23:431-436.
20. Rosenbaum SJ, Lind T, Antoch G, et al. False-positive FDG PET uptake - the role of PET/CT. Eur Radiol. 2006;16:1054-1065.
21. Belhocine T, Blockmans D, Hustinx R, et al. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med MoI Imaging. 2003;30:1305-1313.
22. Bural GG, Torigian DA, Chamroonrat W, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2008;35:562-569.
23. Schouten O, van Laanen JH, Boersma E, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006;32:21-26.
24. Abisi S, Burnand KG, Humphries J, et al. Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms. Br J Surg. 2008;95:333-7.
25. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831.
26. Ben-Haim S, Kupzov E, Tamir A, et al. Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol. 2006;13:791-800.